How do you approach treatment and surveillance of breast cancers in patients carrying germline MUTYH mutation?   

NCCN guidelines do not currently recommend any increased breast cancer surveillance for MUTYH carriers. However, patients might still be eligible for increased breast screening based on family history of breast cancer which would need to be evaluated separately. Currently, this mutation d...